2. Academic Validation
  3. Cyclo-(Phe-Tyr) reduces cerebral ischemia/reperfusion-induced blood-brain barrier dysfunction through regulation of autophagy

Cyclo-(Phe-Tyr) reduces cerebral ischemia/reperfusion-induced blood-brain barrier dysfunction through regulation of autophagy

  • Food Funct. 2022 Nov 28;13(23):12278-12290. doi: 10.1039/d2fo02367a.
Jiayin Liang 1 2 3,  Jiale Cai 1 2 3,  Yutong Zhang 1,  Meixia Xie 1 2 3,  Xiaoshi Li 4,  Tao Hu 1 2 3,  Shengwang Liang 1 2 3,  Minghua Xian 1 2 3,  Shumei Wang 1 2 3
Affiliations

Affiliations

  • 1 Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, 280 Waihuan Rd E, Guangzhou, Guangdong, 510006, China. [email protected].
  • 2 Key Laboratory of Digital Quality Evaluation of Traditional Chinese Medicine, National Administration of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510006, China.
  • 3 Traditional Chinese Medicine Quality Engineering and Technology Research Center of Guangdong Universities, Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510006, China.
  • 4 Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, 518055, China.
PMID: 36345882 DOI: 10.1039/d2fo02367a
Abstract

Cerebral ischemia/reperfusion (I/R) injury is the result of ischemic stroke, a serious threat to public health. I/R injury can damage the blood-brain barrier (BBB), adversely affecting the brain environment and aggravating the injury. Cyclo-(Phe-Tyr) (sparganin C, SC) is a small molecule derived from the Chinese yam Dioscorea opposita Thunb. or Sparganii rhizoma. In our previous study, SC mitigates I/R injury both in vivo and in vitro through the action of JUNB and SOX5. However, the exact pharmacological effects of SC on BBB protection after an I/R injury remain unclear. We constructed a rat model of middle cerebral artery occlusion-reperfusion (MCAO/R) injury to evaluate the therapeutic actions of SC, and the integrity of the BBB was evaluated by ELISA, western blotting, and Evans blue staining. It was found that SC significantly reduced the amount of Evans blue staining in the brain, inhibited the expression of inflammatory factors IL-6, IL-1β, IL-17, IL-23, and TNF-α as well as TIPM1/MMP proteins, and promoted the expression of the tight junction proteins occludin, ZO-1, and claudin-5. SC was found to inhibit the excess Autophagy induced by I/R injury to protect BBB integrity through the PI3K/Akt/mTOR pathway, and the PI3K Inhibitor LY294002 significantly reduced the SC-mediated protection. Overall, this is the first demonstration of the alleviation of BBB damage caused by I/R injury by SC and suggests a potential treatment for the effects of an ischemic stroke.

Figures
Products